<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Electron Physician</journal-id><journal-id journal-id-type="iso-abbrev">Electron Physician</journal-id><journal-id journal-id-type="publisher-id">Electronic physician</journal-id><journal-title-group><journal-title>Electronic Physician</journal-title></journal-title-group><issn pub-type="epub">2008-5842</issn><publisher><publisher-name>Electronic physician</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27382438</article-id><article-id pub-id-type="pmc">4930248</article-id><article-id pub-id-type="doi">10.19082/2308</article-id><article-id pub-id-type="publisher-id">epj-08-2308</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Effect of Prophylactic Antibiotics on Post Laparoscopic Cholecystectomy Infectious Complications: A Double-Blinded Clinical Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Darzi</surname><given-names>Ali Asghar</given-names></name><xref ref-type="aff" rid="af1-epj-08-2308">1</xref></contrib><contrib contrib-type="author"><name><surname>Nikmanesh</surname><given-names>Alieh</given-names></name><xref ref-type="aff" rid="af2-epj-08-2308">2</xref></contrib><contrib contrib-type="author"><name><surname>Bagherian</surname><given-names>Farhad</given-names></name><xref ref-type="aff" rid="af3-epj-08-2308">3</xref><xref ref-type="corresp" rid="c1-epj-08-2308"/></contrib></contrib-group><aff id="af1-epj-08-2308"><label>1</label>Assistant Professor, Department of Surgery, Clinical Research Development Center, Babol University of Medical Sciences, Babol, Iran</aff><aff id="af2-epj-08-2308"><label>2</label>Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran</aff><aff id="af3-epj-08-2308"><label>3</label>Assistant Professor, Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran</aff><author-notes><corresp id="c1-epj-08-2308">Corresponding author: Assistant Professor Dr. Farhad Bagherian, Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran. Tel: +98.9111152946, Email: <email>dr_f_bagherian@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><month>5</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>25</day><month>5</month><year>2016</year></pub-date><volume>8</volume><issue>5</issue><fpage>2308</fpage><lpage>2314</lpage><history><date date-type="received"><day>03</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>04</day><month>3</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 The Authors</copyright-statement><copyright-year>2016</copyright-year><license><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><sec><title>Background</title><p>Laparoscopic cholecystectomy (LC) is one of the most common surgeries in laparoscopic surgery. Although, it is believed that LC has low-risk for post-operative infectious complications, the use of a prophylactic antibiotic is still controversial in elective LC.</p></sec><sec><title>Objective</title><p>To determine the impact of prophylactic antibiotics on postoperative infection complications in elective laparoscopic cholecystectomy.</p></sec><sec><title>Methods</title><p>In this double-blind, placebo-controlled, randomized, clinical trial, patients who were candidates for elective LC, from March 2012 to 2015, in four hospitals in Babol, Iran, were studied. Patients were allocated randomly to two groups, i.e., group C: Cefazolin (n = 182) and group P: placebo (n = 247). Group C received 1 g of Cefazolin 30 minutes before anesthesia and and then, six and 12 hours after anesthesia. Group P patients received 10 ml of isotonic sodium chloride solution. Age, gender, type of gallbladder diseases (stone, polyp, or hydrops), the length of post-operative hospitalization, frequency of gallbladder rupture, the duration of surgery, and the kinds of complications associated with infections were collected for each patient in the two groups. The data were analyzed by IBM-SPSS version 20, using the t-test and the chi-squared test, and a p-value &#x0003c; 0.05 was considered as significant.</p></sec><sec><title>Results</title><p>There were no significant differences between the two groups in terms of gender (C versus P: 18 (9.9%) male versus 22 (9%); p = 0.74), age (C versus P: 43.75 + 13.30 years versus 40.91 + 13.05; p = 0.20), and duration of surgery (C versus P: 34.97 &#x000b1; 8.25 min versus 34.11 &#x000b1; 8.39; p = 0.71). There were no significant differences between the two groups in the incidences of post-operative infection (C versus P: 3 (1.7%) versus 5 (2%); p = 0.99) and rupture of the gallbladder (C versus P: 14 (7.8%) versus 17 (6.8%); p = 0.85). No other post-operative systemic infectious complications (e.g., sepsis, pneumonia, or urinary tract infection) were found in either group.</p></sec><sec><title>Conclusion</title><p>For patients who underwent laparoscopic cholecystectomy (LC), prophylactic antibiotics had no important role in the prevention of infections; so these antibiotics apparently are not necessary in treatment, and they are not recommended for patients with laparoscopic cholecystectomy as low-risk selective antibiotics.</p></sec><sec><title>Trial registration</title><p>The trial was registered at the Iranian Clinical Trial Registry (<ext-link ext-link-type="uri" xlink:href="http://www.irct.ir">http://www.irct.ir</ext-link>) with the IRCT identification number IRCT2013070413865N1.</p></sec><sec><title>Funding</title><p>This research was supported financially by the Research Council of Babol University of Medical Sciences.</p></sec></abstract><kwd-group><kwd>Antibiotic prophylaxis</kwd><kwd>Surgical wound infection</kwd><kwd>Laparoscopic cholecystectomy</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>In patients with symptomatic cholelithiasis during open cholecystectomy operations, the first choice for treatment should be laparoscopic cholecystectomy (<xref rid="b1-epj-08-2308" ref-type="bibr">1</xref>&#x02013;<xref rid="b2-epj-08-2308" ref-type="bibr">2</xref>) because of the slight probability of post-operative infections due to the creation of tiny wounds as well as tissue damage, which is less common in LP than open surgery (<xref rid="b1-epj-08-2308" ref-type="bibr">1</xref>). Surgical site infections (SSIs) are infections that occur in the wound created by an invasive surgical procedure, and they are the common cause of healthcare-associated infections (<xref rid="b1-epj-08-2308" ref-type="bibr">1</xref>&#x02013;<xref rid="b4-epj-08-2308" ref-type="bibr">4</xref>). Three meta-analyses based on the use of retrospective studies indicated that, after cholecystectomy, the mean ratio of infectivity by microorganisms in the wound sites was in the range of 0.4 &#x02013; 1.1% (<xref rid="b2-epj-08-2308" ref-type="bibr">2</xref>&#x02013;<xref rid="b4-epj-08-2308" ref-type="bibr">4</xref>). The use of prophylactic antibiotics in the study was shown to prevent surgical site infections (SSIs), thereby preventing the obvious infectious side effects in open cholecystectomy; of course, according to several surveys that have been conducted in various parts of the world, these antibiotics are neither appropriate nor necessary for this purpose (<xref rid="b5-epj-08-2308" ref-type="bibr">5</xref>&#x02013;<xref rid="b13-epj-08-2308" ref-type="bibr">13</xref>). However, there is no consensus on these considerations, and many surgeons still use antibiotic prophylaxis in laparoscopic cholecystectomy and also recommend the administration of prophylactic antibiotics (<xref rid="b13-epj-08-2308" ref-type="bibr">13</xref>&#x02013;<xref rid="b18-epj-08-2308" ref-type="bibr">18</xref>). However, these meta-analyses were conducted at a different time, and on studies with relatively small sample sizes. Cefazolin - a first-generation cephalosporin - has the favorable pharmacokinetic properties of sufficient distribution to the wall of the gallbladder and a high concentration in the bile (<xref rid="b19-epj-08-2308" ref-type="bibr">19</xref>, <xref rid="b20-epj-08-2308" ref-type="bibr">20</xref>). Because of its low toxicity, broad-spectrum anti-microbial effect, and low cost, a single dose of the antibiotic cefazolin is effective in patients with open cholecystectomy and other biliary surgery (<xref rid="b21-epj-08-2308" ref-type="bibr">21</xref>, <xref rid="b22-epj-08-2308" ref-type="bibr">22</xref>). Thus, it is the antibiotic that is recommended by the U.S. Center for Disease Control and Prevention as being suitable for preventing SSIs (<xref rid="b23-epj-08-2308" ref-type="bibr">23</xref>, <xref rid="b24-epj-08-2308" ref-type="bibr">24</xref>). However, to date, the effectiveness of Cefazolin on post-LC infective complications remains unclear. The aim of this study was to determine the efficacy of prophylactic Cefazolin on the rate of post laparoscopic cholecystectomy infectious complications.</p></sec><sec><title>2. Material and methods</title><sec sec-type="methods"><title>2.1. Study design</title><p>This was a double-blinded, randomized, clinical trial conducted on patients who were candidates for elective LC due to symptomatic gallbladder stones or polyps and who were referred to four major hospitals in Babol, Iran, from March 2012 to March 2015.</p></sec><sec sec-type="methods"><title>2.2. Study population</title><p>The inclusion criteria were ages more than 18 years old and a first-time abdominal surgery. The exclusion criteria were patients who were younger than 18 and older than 75, antibiotic consumption in seven days before the LC, immune compromised patients, history of acute cholecystitis in the six months prior to admission, concomitant choledocholithiasis, intrahepatic duct stones, evidence of cholangitis and/or obstructive jaundice and gallstone pancreatitis, previous biliary tract surgery or previous endoscopic retrograde colangiopancreato- garaphy within a week before the surgery, diabetes mellitus, massive bleeding during surgery, converting laparoscopy to laparotomy, cephalosporin or beta-lactam allergy, sensitivity, or anaphylaxis, major thalassemia, and empyema.</p></sec><sec><title>2.3. Sample size determination</title><p>According to previous studies that showed an overall rate of infection of 1.1% (<xref rid="b4-epj-08-2308" ref-type="bibr">4</xref>), we estimated a sample size of 167 in each group using &#x003b1; value of 0.05 with a power of 80% and a precision of 1%.</p></sec><sec><title>2.4. Blinding and allocation</title><p>Patients were allocated randomly using closed envelopes that contained one of the intervention protocols. They were allocated to two groups, i.e., group C: Cefazolin group (n = 182) and group P: Placebo group (n = 247) (<xref ref-type="fig" rid="f1-epj-08-2308">Figure 1</xref>). The intervention plan of each group was prepared by a nurse who was not a member of our research team, and the plan was delivered to the anesthesiologist. The patients were not aware of the type of solution that was used. The medical staff and the patient were unaware of the content of the solution.</p></sec><sec><title>2.5. Interventions</title><p>Group C patients received 1 gr of Cefazolin 30 minutes before anesthesia and and then, six and 12 hours after anesthesia. Group P patients received 10 ml of isotonic sodium chloride solution with the same prescribing method of Cefazolin. Operations were conducted on all of the patients using reusable laparoscopic instruments that were sterilized with ethylene oxide. The skin was prepared with a 10% povidone-iodine solution. LC was done with a 4-trocar standard technique; a 10-mm trocar was placed with the open technique through an infra-umbilical incision (Hasson). A 2-0 non-absorbable, monofilament suture was used to close the incision, but the other ones were applied under direct vision as follows: 5-mm trocar on the midclavicular line, 10-mm trocar in the epigastrium, and 5-mm trocar in the right flank in line with the gallbladder fundus; the extraction hole created by the trocar in the epigastric region was opened to remove the ruptured gallbladders that had severe inflammation and friability using a plastic bag and positional peritoneal irrigation without any drain, and 3-0, non-absorbable, monofilament sutures were used in the other incisions.</p></sec><sec><title>2.6. Outcomes</title><p>Before the interventions, the subjects&#x02019; genders and ages were documented. During the operation, surgery time and evidence of ruptured gallbladder also were recorded. The post-operative course was monitored, and the duration of hospital stay and any evidence of superficial SSI or any incidents, such as fever (&#x0003e; 38 &#x000b0;C, temperature taken twice a day, excluding the first postoperative day), infection of the trocar site (purulent drainage from the surgical sites), and intra-abdominal collection of pus were recorded in checklists. After being discharged from the hospital, the patients underwent weekly, clinical, post-operative monitoring for SSI for a one-month period.</p></sec><sec><title>2.7. Ethics</title><p>This study was approved by the Ethics Committee of Babol University of Medical Sciences, and all of the subjects&#x02019; parents were informed regarding the details of the study, and they signed a consent form. This study was registered in the Iranian Registry of Clinical Trials with the registration number of IRCT 20130704138651.</p></sec><sec sec-type="methods"><title>2.8. Statistical analysis</title><p>All of the variables had a normal distribution. Statical analysis, such as the t-test, chi-squared test, and &#x02018;Fisher exact test,&#x02019; as appropriate, were done using IBM-SPSS version 20 considering a p-value &#x0003c; 0.05 as significant.</p></sec></sec><sec><title>3. Results</title><sec sec-type="intro"><title>3.1. Baseline characteristics</title><p>Four hundred and twenty-nine patients, including 40 males and 389 females with a mean age of 42.08 &#x000b1; 13.1 years, were enrolled in two groups, i.e., Group C (n = 182) and Group P (n = 247). There was no statistically significant difference between the two groups in term of gender (p = 0. 74), age (p = 0.2), or the duration of surgery (p = 0.17) (<xref ref-type="table" rid="t1-epj-08-2308">Table 1</xref>).</p></sec><sec><title>3.2. Surgery outcomes</title><p>The results of surgery indicated that the mean length of the LC operation was 34.43 &#x000b1; 8.25 min and that the rate of gallbladder rupture was 7.25%. No significant different was observed between the two groups in the mean duration of the LC operation or the rate of gallbladder rupture (<xref ref-type="table" rid="t1-epj-08-2308">Table 1</xref>). Post-operative follow-up showed that the average duration of hospital stay was 1.02 &#x000b1; 0.13 days. Post-LC superficial SSIs were observed in eight patients (1.9%). Group C had three superficial SSIs (1.7%), i.e., one at the umbilical port site and two at the epigastric incision site; in Group P, five patients had superficial SSIs (2%), i.e., two at the umbilical port site and three at the epigastric port site. No other post-operative systemic infectious complications (e.g., sepsis, pneumonia, or urinary tract infections) occurred in either group. SSIs occurred in three out of 31 patients who had gallbladder rupture, and they occurred in five out of 398 patients without gallbladder rupture. The risk of infectious complications increased in patients who had ruptured gallbladders (p = 0.001) and in male patients (p = 0.03) (<xref ref-type="table" rid="t2-epj-08-2308">Table 2</xref>).</p></sec></sec><sec><title>4. Discussion</title><p>Our data showed that the overall rate of SSIs after LC was just 1.9%, and it was not related to the use of a Cefazolin (1 g), which was lower than the rate of post-LC SSIs that has been reported in the literature, i.e., about 0.4% and 6.3% (<xref rid="b4-epj-08-2308" ref-type="bibr">4</xref>, <xref rid="b6-epj-08-2308" ref-type="bibr">6</xref>, <xref rid="b8-epj-08-2308" ref-type="bibr">8</xref>, <xref rid="b13-epj-08-2308" ref-type="bibr">13</xref>, <xref rid="b15-epj-08-2308" ref-type="bibr">15</xref>, <xref rid="b24-epj-08-2308" ref-type="bibr">24</xref>). The patients treated with or without prophylactic antibiotics showed different rates of SSIs, i.e., about 1.7% and 2.1%, respectively, but the difference was not statistically significant. Actually, thesde rates were lower than the rates reported in other studies on open cholecystectomy (<xref rid="b4-epj-08-2308" ref-type="bibr">4</xref>, <xref rid="b25-epj-08-2308" ref-type="bibr">25</xref>). In open cholecystectomy and other biliary surgery, Cefazolin is an effective antibiotic (<xref rid="b18-epj-08-2308" ref-type="bibr">18</xref>, <xref rid="b19-epj-08-2308" ref-type="bibr">19</xref>). Also, studies have shown that, for induction of anesthesia or immediately before cutting in clean or clean-contaminated procedures, cephalosporin should be adminsistered intravenously as a single dose (<xref rid="b22-epj-08-2308" ref-type="bibr">22</xref>). However, the aim of antimicrobial prophylaxis is to reduce the number of microorganisms to such an extent that the defense mechanism of the host can effectively prevent infection by the contaminating microorganisms; it is not to completely eradicate microorganisms from the tissue (<xref rid="b26-epj-08-2308" ref-type="bibr">26</xref>). Whether antibiotic prophylaxis has any effect on the occurrence of postoperative infections in LC remains controversial (<xref rid="b2-epj-08-2308" ref-type="bibr">2</xref>, <xref rid="b4-epj-08-2308" ref-type="bibr">4</xref>, <xref rid="b5-epj-08-2308" ref-type="bibr">5</xref>, <xref rid="b7-epj-08-2308" ref-type="bibr">7</xref>, <xref rid="b14-epj-08-2308" ref-type="bibr">14</xref>, <xref rid="b15-epj-08-2308" ref-type="bibr">15</xref>, <xref rid="b27-epj-08-2308" ref-type="bibr">27</xref>&#x02013;<xref rid="b30-epj-08-2308" ref-type="bibr">30</xref>). Infectious side effects in laparoscopic cholecystectomy can be prevented mainly by administering prophylactic antibiotics (<xref rid="b14-epj-08-2308" ref-type="bibr">14</xref>&#x02013;<xref rid="b16-epj-08-2308" ref-type="bibr">16</xref>), and these results were contrary to other findings obtained from several prospective surveys, so that the use of these antibiotics are unnecessary due to the low rates of infection during LC (<xref rid="b4-epj-08-2308" ref-type="bibr">4</xref>, <xref rid="b5-epj-08-2308" ref-type="bibr">5</xref>, <xref rid="b7-epj-08-2308" ref-type="bibr">7</xref>, <xref rid="b34-epj-08-2308" ref-type="bibr">34</xref>). The various benefits of laparoscopy categorized as an elective method include less post-operative pain, shorter hospital stay, faster resumption of food intake and work, and a significant reduction in perioperative infectious complications (<xref rid="b1-epj-08-2308" ref-type="bibr">1</xref>, <xref rid="b31-epj-08-2308" ref-type="bibr">31</xref>&#x02013;<xref rid="b33-epj-08-2308" ref-type="bibr">33</xref>). Similar to previous studies, our results showed that there were no significant differences in the infection rate between the two groups of users of prophylactic antibiotic. Many reports also have indicated that wound infections are not related to rupture of gallbladders (<xref rid="b5-epj-08-2308" ref-type="bibr">5</xref>, <xref rid="b35-epj-08-2308" ref-type="bibr">35</xref>). However, like other studies, our study also demonstrated that ruptures of the gallbladder contributed to the increased rates of post-operative infections (<xref rid="b38-epj-08-2308" ref-type="bibr">38</xref>, <xref rid="b39-epj-08-2308" ref-type="bibr">39</xref>). Perforation during gallbladder surgery is attributed to traction, grasping, dissection, and removal of the gallbladder, which is likely to occur in 11 to 35% of LC cases (<xref rid="b4-epj-08-2308" ref-type="bibr">4</xref>, <xref rid="b7-epj-08-2308" ref-type="bibr">7</xref>, <xref rid="b14-epj-08-2308" ref-type="bibr">14</xref>, <xref rid="b34-epj-08-2308" ref-type="bibr">34</xref>). In this study, rupture of the gallbladder occurred in 7.7 and 6.9% of patients in groups C and P, respectively. There was a significant association between intraoperative gallbladder rupture and SSI (p = 0.001), whereas many reports have indicated that wound infections were not related to rupture of the gallbladder (<xref rid="b5-epj-08-2308" ref-type="bibr">5</xref>, <xref rid="b35-epj-08-2308" ref-type="bibr">35</xref>). Patients with laparoscopic interventions treated by antibiotic prophylaxis were examined by Goldfan and Birkenmeier in 1990 within 98 randomized works, and they concluded that these antibiotics are not necessary in low-risk patients (<xref rid="b37-epj-08-2308" ref-type="bibr">37</xref>). According to the results of this and other studies, it should be noted that the causes of the low incidence of infections after laparoscopy can be attributed to minor surgical trauma, patient mobilization, faster resumption of permitted nutrition, and avoiding the administration of prophylactic antibiotics (<xref rid="b7-epj-08-2308" ref-type="bibr">7</xref>, <xref rid="b9-epj-08-2308" ref-type="bibr">9</xref>). Other researchers have shown that major infectious complications, such as bile leak, intra-abdominal abscesses, and acute pancreatitis, usually are caused by technical problems instead of prophylactic antibiotics, so various parameters, including the delicacy of surgical techniques and other non-antibiotic-based physical and prophylactic methods, are considered more significant in the prevention process (<xref rid="b7-epj-08-2308" ref-type="bibr">7</xref>, <xref rid="b8-epj-08-2308" ref-type="bibr">8</xref>, <xref rid="b36-epj-08-2308" ref-type="bibr">36</xref>). Other substantial factors of SSIs are associated with mechanical damage to tissues and contamination with the microflora from the skin (<xref rid="b5-epj-08-2308" ref-type="bibr">5</xref>, <xref rid="b10-epj-08-2308" ref-type="bibr">10</xref>, <xref rid="b25-epj-08-2308" ref-type="bibr">25</xref>, <xref rid="b35-epj-08-2308" ref-type="bibr">35</xref>, <xref rid="b36-epj-08-2308" ref-type="bibr">36</xref>).</p></sec><sec><title>5. Conclusions</title><p>Considering the low rate of observed post-LC operation SSI in this study and the fact that there was no significant different between the two groups of patients who used prophylactic antibiotics and those who did not, it seems that the use of Cefazolin does not lower the rate of SSIs. Therefore, the use of prophylactic antibiotics is not recommended for patients undergoing LC.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Mrs. Sakineh Kamali Ahangar, who is on the staff of the Clinical Research and Development Group at Shahid Beheshti Hospital in Babol, Iran, for her scientific support during this trial.</p></ack><fn-group><fn id="fn1-epj-08-2308"><p>iThenticate screening: March 04, 2016, English editing: March 12, 2016, Quality control: May 02, 2016</p></fn><fn id="fn2-epj-08-2308"><p><bold>Funding:</bold> This research was supported financially by the Research Council at Babol University of Medical Sciences. The authors received no financial assistance for the authorship and publication of this article.</p></fn><fn id="fn3-epj-08-2308"><p><bold>Trial registration:</bold> The trial was registered at the Iranian Clinical Trial Registry (<ext-link ext-link-type="uri" xlink:href="http://www.irct.ir">http://www.irct.ir</ext-link>) with the IRCT identification number IRCT2013070413865N1.</p></fn><fn id="fn4-epj-08-2308"><p><bold>Conflict of Interest:</bold> There is no conflict of interest to be declared.</p></fn><fn id="fn5-epj-08-2308"><p><bold>Authors&#x02019; contributions:</bold> All authors contributed to this project and article equally. All authors read and approved the final manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-epj-08-2308"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shea</surname><given-names>JA</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><name><surname>Bachwich</surname><given-names>DR</given-names></name><name><surname>Staroscik</surname><given-names>RN</given-names></name><name><surname>Malet</surname><given-names>PF</given-names></name><name><surname>McGuckin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Indications for and outcomes of cholecystectomy: a comparison of the pre and post laparoscopiceras</article-title><source>Ann Surg</source><year>1998</year><volume>227</volume><fpage>343</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1097/00000658-199803000-00005</pub-id><!--<pub-id pub-id-type="pmcid">PMC1191271</pub-id>--><pub-id pub-id-type="pmid">9527056</pub-id></element-citation></ref><ref id="b2-epj-08-2308"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGuckin</surname><given-names>M</given-names></name><name><surname>Shea</surname><given-names>JA</given-names></name><name><surname>Schwartz</surname><given-names>JS</given-names></name></person-group><article-title>Infection and antimicrobial use in laparoscopic cholecystectomy</article-title><source>Infect Control Hosp Epidemiol</source><year>1999</year><volume>20</volume><fpage>624</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1086/501685</pub-id><pub-id pub-id-type="pmid">10501264</pub-id></element-citation></ref><ref id="b3-epj-08-2308"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shea</surname><given-names>JA</given-names></name><name><surname>Healey</surname><given-names>MJ</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><name><surname>Clarke</surname><given-names>JR</given-names></name><name><surname>Malet</surname><given-names>PF</given-names></name><name><surname>Staroscik</surname><given-names>RN</given-names></name><etal/></person-group><article-title>Mortality and complications associated with laparoscopic cholecystectomy. A meta-analysis</article-title><source>Ann Surg</source><year>1996</year><volume>224</volume><fpage>609</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1097/00000658-199611000-00005</pub-id><!--<pub-id pub-id-type="pmcid">PMC1235438</pub-id>--><pub-id pub-id-type="pmid">8916876</pub-id></element-citation></ref><ref id="b4-epj-08-2308"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>WT</given-names></name><name><surname>Lee</surname><given-names>KT</given-names></name><name><surname>Chuang</surname><given-names>SC</given-names></name><name><surname>Wang</surname><given-names>SN</given-names></name><name><surname>Kuo</surname><given-names>KK</given-names></name><name><surname>Chen</surname><given-names>JS</given-names></name><etal/></person-group><article-title>The impact of prophylactic antibiotics on postoperative infection complication in elective laparoscopic cholecystectomy: a prospective randomized study</article-title><source>Am J Surg</source><year>2006</year><volume>191</volume><fpage>721</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2006.01.050</pub-id><pub-id pub-id-type="pmid">16720138</pub-id></element-citation></ref><ref id="b5-epj-08-2308"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koc</surname><given-names>M</given-names></name><name><surname>Zulfikaro&#x0011f;lu</surname><given-names>B</given-names></name><name><surname>Kece</surname><given-names>C</given-names></name><name><surname>Ozalp</surname><given-names>N</given-names></name></person-group><article-title>A prospective randomized study of prophylactic antibiotics in elective laparoscopic cholecystectomy</article-title><source>Surg Endosc</source><year>2003</year><volume>17</volume><fpage>1716</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1007/s00464-002-8866-y</pub-id><pub-id pub-id-type="pmid">12802644</pub-id></element-citation></ref><ref id="b6-epj-08-2308"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahatharadol</surname><given-names>V</given-names></name></person-group><article-title>A reevaluation of antibiotic prophylaxis in laparoscopic cholecystectomy: a randomized controlled trial</article-title><source>J Med Assoc Thai</source><year>2001</year><volume>84</volume><fpage>105</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11281486</pub-id></element-citation></ref><ref id="b7-epj-08-2308"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tocchi</surname><given-names>A</given-names></name><name><surname>Lepre</surname><given-names>L</given-names></name><name><surname>Costa</surname><given-names>G</given-names></name><name><surname>Liotta</surname><given-names>G</given-names></name><name><surname>Mazzoni</surname><given-names>G</given-names></name><name><surname>Maggiolini</surname><given-names>F</given-names></name></person-group><article-title>The need for antibiotic prophylaxis in elective laparoscopic cholecystectomy: a prospective randomized study</article-title><source>Arch Surg</source><year>2000</year><volume>135</volume><fpage>67</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1001/archsurg.135.1.67</pub-id><pub-id pub-id-type="pmid">10636350</pub-id></element-citation></ref><ref id="b8-epj-08-2308"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>A</given-names></name><name><surname>London</surname><given-names>J</given-names></name><name><surname>Charland</surname><given-names>S</given-names></name><name><surname>Ratzer</surname><given-names>E</given-names></name><name><surname>Clark</surname><given-names>J</given-names></name><name><surname>Haun</surname><given-names>W</given-names></name><etal/></person-group><article-title>Prophylactic antibiotics for elective laparoscopic cholecystectomy: are they necessary?</article-title><source>Arch Surg</source><year>1999</year><volume>134</volume><fpage>611</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1001/archsurg.134.6.611</pub-id><pub-id pub-id-type="pmid">10367869</pub-id></element-citation></ref><ref id="b9-epj-08-2308"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harling</surname><given-names>R</given-names></name><name><surname>Moorjani</surname><given-names>N</given-names></name><name><surname>Perry</surname><given-names>C</given-names></name><name><surname>MacGowan</surname><given-names>AP</given-names></name><name><surname>Thompson</surname><given-names>MH</given-names></name></person-group><article-title>A prospective, randomized trial of prophylactic antibiotics versus bag extraction in the prophylaxis of wound infection in laparoscopic cholecystectomy</article-title><source>Ann R Coll Surg Engl</source><year>2000</year><volume>82</volume><fpage>408</fpage><lpage>10</lpage><!--<pub-id pub-id-type="pmcid">PMC2503474</pub-id>--><pub-id pub-id-type="pmid">11103159</pub-id></element-citation></ref><ref id="b10-epj-08-2308"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illig</surname><given-names>KA</given-names></name><name><surname>Schmidt</surname><given-names>E</given-names></name><name><surname>Cavanaugh</surname><given-names>J</given-names></name><name><surname>Krusch</surname><given-names>D</given-names></name><name><surname>Sax</surname><given-names>HC</given-names></name></person-group><article-title>Are prophylactic antibiotics required for elective laparoscopic cholecystectomy?</article-title><source>J Am Coll Surg</source><year>1997</year><volume>184</volume><fpage>353</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9100679</pub-id></element-citation></ref><ref id="b11-epj-08-2308"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobay</surname><given-names>KJ</given-names></name><name><surname>Freier</surname><given-names>DT</given-names></name><name><surname>Albear</surname><given-names>P</given-names></name></person-group><article-title>The absent role of prophylactic antibiotics in low-risk patients undergoing laparoscopic cholecystectomy</article-title><source>Am Surg</source><year>1999</year><volume>65</volume><fpage>226</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10075297</pub-id></element-citation></ref><ref id="b12-epj-08-2308"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuthe</surname><given-names>SA</given-names></name><name><surname>Kaman</surname><given-names>L</given-names></name><name><surname>Verma</surname><given-names>GR</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name></person-group><article-title>Evaluation of the role of prophylactic antibiotics in elective laparoscopic cholecystectomy: a prospective randomized trial</article-title><source>Trop Gastroenterol</source><year>2006</year><volume>27</volume><fpage>54</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16910066</pub-id></element-citation></ref><ref id="b13-epj-08-2308"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippert</surname><given-names>H</given-names></name><name><surname>Gastinger</surname><given-names>J</given-names></name></person-group><article-title>Antimicrobial prophylaxis in laparoscopic and conventional cholecystectomy. Conclusions of a large prospective multicenter quality assurance study in Germany</article-title><source>Chemotherapy</source><year>1998</year><volume>44</volume><fpage>355</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1159/000007135</pub-id><pub-id pub-id-type="pmid">9732152</pub-id></element-citation></ref><ref id="b14-epj-08-2308"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchiyama</surname><given-names>K</given-names></name><name><surname>Kawai</surname><given-names>M</given-names></name><name><surname>Onishi</surname><given-names>H</given-names></name><name><surname>Tani</surname><given-names>M</given-names></name><name><surname>Kinoshita</surname><given-names>H</given-names></name><name><surname>Ueno</surname><given-names>M</given-names></name><etal/></person-group><article-title>Preoperative antimicrobial administration for prevention of postoperative infection in patients with laparoscopic cholecystectomy</article-title><source>Dig Dis Sci</source><year>2003</year><volume>48</volume><fpage>1955</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1023/A:1026114203622</pub-id><pub-id pub-id-type="pmid">14627340</pub-id></element-citation></ref><ref id="b15-epj-08-2308"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shindholimath</surname><given-names>VV</given-names></name><name><surname>Seenu</surname><given-names>V</given-names></name><name><surname>Parshad</surname><given-names>R</given-names></name><name><surname>Chaudhry</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>Factors influencing wound infection following laparoscopic cholecystectomy</article-title><source>Trop Gastroenterol</source><year>2003</year><volume>24</volume><fpage>90</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">14603831</pub-id></element-citation></ref><ref id="b16-epj-08-2308"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dervisoglou</surname><given-names>A</given-names></name><name><surname>Tsiodras</surname><given-names>S</given-names></name><name><surname>Kanellakopoulou</surname><given-names>K</given-names></name><name><surname>Pinis</surname><given-names>S</given-names></name><name><surname>Galanakis</surname><given-names>N</given-names></name><name><surname>Pierakakis</surname><given-names>S</given-names></name><etal/></person-group><article-title>The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime vs ampicillin-sulbactam</article-title><source>Arch Surg</source><year>2006</year><volume>141</volume><fpage>1162</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/archsurg.141.12.1162</pub-id><pub-id pub-id-type="pmid">17178957</pub-id></element-citation></ref><ref id="b17-epj-08-2308"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarli</surname><given-names>L</given-names></name><name><surname>Pietra</surname><given-names>N</given-names></name><name><surname>Costi</surname><given-names>R</given-names></name><name><surname>Grattarola</surname><given-names>M</given-names></name></person-group><article-title>Gallbladder perforation during laparoscopic cholecystectomy</article-title><source>World J Surg</source><year>1999</year><volume>23</volume><fpage>1186</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/s002689900644</pub-id><pub-id pub-id-type="pmid">10501883</pub-id></element-citation></ref><ref id="b18-epj-08-2308"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westphal</surname><given-names>JF</given-names></name><name><surname>Brogard</surname><given-names>JM</given-names></name></person-group><article-title>Biliary tract infections: a guide to drug treatment</article-title><source>Drugs</source><year>1999</year><volume>57</volume><issue>1</issue><fpage>81</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.2165/00003495-199957010-00007</pub-id><pub-id pub-id-type="pmid">9951953</pub-id></element-citation></ref><ref id="b19-epj-08-2308"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>R</given-names></name><name><surname>Sorrell</surname><given-names>TC</given-names></name></person-group><article-title>Biliary sepsis. Reviewing treatment options</article-title><source>Drugs</source><year>1986</year><volume>31</volume><issue>5</issue><fpage>449</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.2165/00003495-198631050-00004</pub-id><pub-id pub-id-type="pmid">3086069</pub-id></element-citation></ref><ref id="b20-epj-08-2308"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittmann</surname><given-names>DH</given-names></name><name><surname>Condon</surname><given-names>RE</given-names></name></person-group><article-title>Prophylaxis of postoperative infections</article-title><source>Infection</source><year>1991</year><volume>19</volume><issue>Suppl 6</issue><fpage>S337</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/BF01715775</pub-id><pub-id pub-id-type="pmid">1791080</pub-id></element-citation></ref><ref id="b21-epj-08-2308"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellum</surname><given-names>JM</given-names></name><name><surname>Duma</surname><given-names>RJ</given-names></name><name><surname>Gorbach</surname><given-names>SL</given-names></name><name><surname>Sugerman</surname><given-names>HJ</given-names></name><name><surname>Haynes</surname><given-names>BW</given-names><suffix>Jr</suffix></name><name><surname>Gervin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Single-dose antibiotic prophylaxis for biliary surgery. Cefazolin vs moxalactam</article-title><source>Arch Surg</source><year>1987</year><volume>122</volume><fpage>918</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1001/archsurg.1987.01400200068012</pub-id><pub-id pub-id-type="pmid">3115228</pub-id></element-citation></ref><ref id="b22-epj-08-2308"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>RL</given-names></name></person-group><article-title>Preventing surgical site infections</article-title><source>Clin Med Res</source><year>2004</year><volume>2</volume><fpage>115</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3121/cmr.2.2.115</pub-id><!--<pub-id pub-id-type="pmcid">PMC1069080</pub-id>--><pub-id pub-id-type="pmid">15931344</pub-id></element-citation></ref><ref id="b23-epj-08-2308"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangram</surname><given-names>AJ</given-names></name><name><surname>Horan</surname><given-names>TC</given-names></name><name><surname>Pearson</surname><given-names>ML</given-names></name><name><surname>Silver</surname><given-names>LC</given-names></name><name><surname>Jarvis</surname><given-names>WR</given-names></name></person-group><article-title>Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee</article-title><source>Infect Control Hosp Epidemiol</source><year>1999</year><volume>20</volume><fpage>250</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1086/501620</pub-id><pub-id pub-id-type="pmid">10219875</pub-id></element-citation></ref><ref id="b24-epj-08-2308"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catarci</surname><given-names>M</given-names></name><name><surname>Mancini</surname><given-names>S</given-names></name><name><surname>Gentileschi</surname><given-names>P</given-names></name><name><surname>Camplone</surname><given-names>C</given-names></name><name><surname>Sileri</surname><given-names>P</given-names></name><name><surname>Grassi</surname><given-names>GB</given-names></name></person-group><article-title>Antibiotic prophylaxis in elective laparoscopic cholecystectomy. Lack of need or lack of evidence?</article-title><source>Surg Endosc</source><year>2004</year><volume>18</volume><fpage>638</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/s00464-003-9090-0</pub-id><pub-id pub-id-type="pmid">14752639</pub-id></element-citation></ref><ref id="b25-epj-08-2308"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Den Hoed</surname><given-names>PT</given-names></name><name><surname>Boelhouwer</surname><given-names>RU</given-names></name><name><surname>Veen</surname><given-names>HF</given-names></name><name><surname>Hop</surname><given-names>WC</given-names></name><name><surname>Bruining</surname><given-names>HA</given-names></name></person-group><article-title>Infections and bacteriological data after laparoscopic and open gallbladder surgery</article-title><source>J Hosp Infect</source><year>1998</year><volume>39</volume><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/S0195-6701(98)90240-7</pub-id><pub-id pub-id-type="pmid">9617682</pub-id></element-citation></ref><ref id="b26-epj-08-2308"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>CP</given-names></name><name><surname>Bohnen</surname><given-names>JM</given-names></name><name><surname>Fletcher</surname><given-names>JR</given-names></name><name><surname>McManus</surname><given-names>AT</given-names></name><name><surname>Solomkin</surname><given-names>JS</given-names></name><name><surname>Wittmann</surname><given-names>DH</given-names></name></person-group><article-title>Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care</article-title><source>Arch Surg</source><year>1993</year><volume>128</volume><issue>1</issue><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1001/archsurg.1993.01420130087014</pub-id><pub-id pub-id-type="pmid">8418785</pub-id></element-citation></ref><ref id="b27-epj-08-2308"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijer</surname><given-names>WS</given-names></name><name><surname>Schmitz</surname><given-names>PI</given-names></name><name><surname>Jeekel</surname><given-names>J</given-names></name></person-group><article-title>Meta-analysis of randomized, controlled clinical trials of antibiotic prophylaxis in biliary tract surgery</article-title><source>Br J Surg</source><year>1990</year><volume>77</volume><issue>3</issue><fpage>283</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1002/bjs.1800770315</pub-id><pub-id pub-id-type="pmid">2138925</pub-id></element-citation></ref><ref id="b28-epj-08-2308"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>RC</given-names></name><name><surname>Shen</surname><given-names>SQ</given-names></name><name><surname>Chen</surname><given-names>ZB</given-names></name><name><surname>Lin</surname><given-names>FS</given-names></name><name><surname>Riley</surname><given-names>J</given-names></name></person-group><article-title>The role of prophylactic antibiotics in laparoscopic cholecystectomy in preventing postoperative infection: a meta- analysis</article-title><source>J Laparoendosc Adv Surg Tech A</source><year>2011</year><volume>21</volume><issue>4</issue><fpage>301</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1089/lap.2010.0436</pub-id><pub-id pub-id-type="pmid">21443433</pub-id></element-citation></ref><ref id="b29-epj-08-2308"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanabria</surname><given-names>A</given-names></name><name><surname>Dominguez</surname><given-names>LC</given-names></name><name><surname>Valdivieso</surname><given-names>E</given-names></name><name><surname>Gomez</surname><given-names>G</given-names></name></person-group><article-title>Antibiotic prophylaxis for Patients undergoing elective laparoscopic cholecystectomy</article-title><source>Cochrane Database Syst Rev</source><year>2010</year><issue>12</issue><fpage>CD005265</fpage><pub-id pub-id-type="doi">10.1002/14651858.cd005265.pub2</pub-id><pub-id pub-id-type="pmid">21154360</pub-id></element-citation></ref><ref id="b30-epj-08-2308"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mir</surname><given-names>MA</given-names></name><name><surname>Malik</surname><given-names>UY</given-names></name><name><surname>Wani</surname><given-names>H</given-names></name><name><surname>Bali</surname><given-names>BS</given-names></name></person-group><article-title>Prevalence, pattern, sensitivity and resistance to antibiotics of different bacteria isolated from port site infection in low risk patients after elective laparoscopic cholecystectomy for symptomatic cholelithiasis at tertiary care hospital of Kashmir</article-title><source>Int Wound J</source><year>2013</year><volume>10</volume><issue>1</issue><fpage>110</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1111/j.1742-481X.2012.00963.x</pub-id><pub-id pub-id-type="pmid">22414004</pub-id></element-citation></ref><ref id="b31-epj-08-2308"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>KJ</given-names></name><name><surname>Miller</surname><given-names>H</given-names></name><name><surname>Fletcher</surname><given-names>DR</given-names></name><name><surname>Jones</surname><given-names>RM</given-names></name><name><surname>Shulkes</surname><given-names>A</given-names></name><name><surname>McNeil</surname><given-names>JJ</given-names></name></person-group><article-title>An evaluation of laparoscopic versus open cholecystectomy</article-title><source>Med J Aust</source><year>1994</year><volume>160</volume><issue>2</issue><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">8309369</pub-id></element-citation></ref><ref id="b32-epj-08-2308"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constant</surname><given-names>E</given-names></name><name><surname>Janssen</surname><given-names>P</given-names></name><name><surname>Nys</surname><given-names>JM</given-names></name><name><surname>el Fouly</surname><given-names>PE</given-names></name><name><surname>Lemmens</surname><given-names>F</given-names></name><name><surname>Hachez</surname><given-names>L</given-names></name><etal/></person-group><article-title>Prospective analysis of 192 consecutive cholecystectomies: a comparative study between laparoscopy and laparotomy</article-title><source>Acta Chir Belg</source><year>1995</year><volume>95</volume><issue>6</issue><fpage>254</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">8571715</pub-id></element-citation></ref><ref id="b33-epj-08-2308"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berggren</surname><given-names>U</given-names></name><name><surname>Gordh</surname><given-names>T</given-names></name><name><surname>Grama</surname><given-names>D</given-names></name><name><surname>Haglund</surname><given-names>U</given-names></name><name><surname>Rastad</surname><given-names>J</given-names></name><name><surname>Arvidsson</surname><given-names>D</given-names></name></person-group><article-title>Laparoscopic versus open cholecystectomy: hospitalization, sick leave, analgesia and trauma responses</article-title><source>Br J Surg</source><year>1994</year><volume>81</volume><issue>9</issue><fpage>1362</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7953415</pub-id></element-citation></ref><ref id="b34-epj-08-2308"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uludag</surname><given-names>M</given-names></name><name><surname>Yetkin</surname><given-names>G</given-names></name><name><surname>Citgez</surname><given-names>B</given-names></name></person-group><article-title>The role of prophylactic antibiotics in elective laparoscopic cholecystectomy</article-title><source>JSLS</source><year>2009</year><volume>13</volume><issue>3</issue><fpage>337</fpage><lpage>41</lpage><!--<pub-id pub-id-type="pmcid">PMC3015970</pub-id>--><pub-id pub-id-type="pmid">19793473</pub-id></element-citation></ref><ref id="b35-epj-08-2308"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold-Deutch</surname><given-names>R</given-names></name><name><surname>Mashiach</surname><given-names>R</given-names></name><name><surname>Boldur</surname><given-names>I</given-names></name><name><surname>Ferszt</surname><given-names>M</given-names></name><name><surname>Negri</surname><given-names>M</given-names></name><name><surname>Halperin</surname><given-names>Z</given-names></name><etal/></person-group><article-title>How does infected bile affect the postoperative course of patients undergoing laparoscopic cholecystectomy?</article-title><source>Am J Surg</source><year>1996</year><volume>172</volume><fpage>272</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/S0002-9610(96)00105-5</pub-id><pub-id pub-id-type="pmid">8862082</pub-id></element-citation></ref><ref id="b36-epj-08-2308"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colizza</surname><given-names>S</given-names></name><name><surname>Rossi</surname><given-names>S</given-names></name><name><surname>Picardi</surname><given-names>B</given-names></name><name><surname>Carnuccio</surname><given-names>P</given-names></name><name><surname>Pollicita</surname><given-names>S</given-names></name><name><surname>Rodio</surname><given-names>F</given-names></name><etal/></person-group><article-title>Surgical infections after laparoscopic cholecystectomy: ceftriaxone vs ceftazidime antibiotic prophylaxis. A prospective study</article-title><source>Chir Ital</source><year>2004</year><volume>56</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">15287637</pub-id></element-citation></ref><ref id="b37-epj-08-2308"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldfaden</surname><given-names>A</given-names></name><name><surname>Birkmeyer</surname><given-names>JD</given-names></name></person-group><article-title>Evidence-based practice in laparoscopic surgery: perioperative care</article-title><source>Surg Innov</source><year>2005</year><volume>12</volume><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1177/155335060501200108</pub-id><pub-id pub-id-type="pmid">15846447</pub-id></element-citation></ref><ref id="b38-epj-08-2308"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>SW</given-names></name><name><surname>Park</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>SE</given-names></name><name><surname>Choi</surname><given-names>YS</given-names></name></person-group><article-title>Accidental gallbladder perforation during laparoscopic cholecystectomy: does it have an effect on the clinical outcomes?</article-title><source>J Laparoendosc Adv Surg Tech A</source><year>2012</year><volume>22</volume><issue>1</issue><fpage>40</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1089/lap.2011.0219</pub-id><pub-id pub-id-type="pmid">22044492</pub-id></element-citation></ref><ref id="b39-epj-08-2308"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turk</surname><given-names>Emin</given-names></name><name><surname>Karagulle</surname><given-names>Erdal</given-names></name><name><surname>Serefhanoglu</surname><given-names>Kivanc</given-names></name><name><surname>Turan</surname><given-names>Hale</given-names></name><name><surname>Moray</surname><given-names>Gokhan</given-names></name></person-group><article-title>Effect of Cefazolin Prophylaxis on Postoperative Infectious Complication in Elective Laparoscopic Cholecystectomy: A Prospective Randomized Study</article-title><source>Iranian red cresent med j</source><year>2013</year><volume>15</volume><issue>7</issue><fpage>581</fpage><lpage>6</lpage><!--<pub-id pub-id-type="pmcid">PMC3871745</pub-id>--></element-citation></ref></ref-list></back><floats-group><fig id="f1-epj-08-2308" position="float"><label>Figure 1</label><caption><p>CONSORT diagram showing how the patients undergoing laparoscopic cholecystectomy were recruited and handled during the course of the study</p></caption><graphic xlink:href="EPJ-08-2308-g001"/></fig><table-wrap id="t1-epj-08-2308" position="float"><label>Table 1</label><caption><p>Baseline characteristics and surgical outcomes of patients who underwent laparoscopic cholecystectomy in the two groups, i.e., the cefazolin group and the placebo group</p></caption><table frame="box" rules="all"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Characteristics</th><th valign="bottom" align="left" rowspan="1" colspan="1">Group cefazolin (n = 182)</th><th valign="bottom" align="left" rowspan="1" colspan="1">Group placebo (n = 247)</th><th valign="bottom" align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender, male/female n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">18 (9.9%)/164 (90.1%)</td><td valign="top" align="left" rowspan="1" colspan="1">22 (9%)/225 (91%)</td><td valign="top" align="left" rowspan="1" colspan="1">0.74</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, year ( mean &#x000b1; SD)</td><td valign="top" align="left" rowspan="1" colspan="1">43.75 &#x000b1; 13.30</td><td valign="top" align="left" rowspan="1" colspan="1">40.91 &#x000b1; 13.05</td><td valign="top" align="left" rowspan="1" colspan="1">0.2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rupture of Gallbladder, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">14 (7.8%)</td><td valign="top" align="left" rowspan="1" colspan="1">17 (6.8%)</td><td valign="top" align="left" rowspan="1" colspan="1">0.85</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Post-operative infection, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">3 (1.7%)</td><td valign="top" align="left" rowspan="1" colspan="1">5 (2%)</td><td valign="top" align="left" rowspan="1" colspan="1">0.99</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Duration of Operation, min (mean &#x000b1; SD)</td><td valign="top" align="left" rowspan="1" colspan="1">34.97 &#x000b1; 8.25</td><td valign="top" align="left" rowspan="1" colspan="1">34.11 &#x000b1; 8.39</td><td valign="top" align="left" rowspan="1" colspan="1">0.17</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Length of Stay, day (mean &#x000b1; SD)</td><td valign="top" align="left" rowspan="1" colspan="1">1.02 &#x000b1; 0.12</td><td valign="top" align="left" rowspan="1" colspan="1">1.02 &#x000b1; 0.15</td><td valign="top" align="left" rowspan="1" colspan="1">0.71</td></tr></tbody></table></table-wrap><table-wrap id="t2-epj-08-2308" position="float"><label>Table 2</label><caption><p>Comparison of the two groups of patients with and without infectious complications during one-month follow-up after laparoscopic cholecystectomy</p></caption><table frame="box" rules="all"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Characteristics</th><th valign="bottom" align="left" rowspan="1" colspan="1">Infectious complications (n=8)</th><th valign="bottom" align="left" rowspan="1" colspan="1">No complications (n=421)</th><th valign="bottom" align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender, male/female, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">3 (37.5%)/5 (62.5%)</td><td valign="top" align="left" rowspan="1" colspan="1">37 (8.8%)/384 (91.2%)</td><td valign="top" align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, year ( mean &#x000b1; SD)</td><td valign="top" align="left" rowspan="1" colspan="1">45.88 &#x000b1; 15.88</td><td valign="top" align="left" rowspan="1" colspan="1">42.05 &#x000b1; 13.17</td><td valign="top" align="left" rowspan="1" colspan="1">0.41</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rupture of Gallbladder, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">3 (37.5%)</td><td valign="top" align="left" rowspan="1" colspan="1">28 (6.7%)</td><td valign="top" align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Duration of Operation, min (mean &#x000b1; SD)</td><td valign="top" align="left" rowspan="1" colspan="1">37.5 &#x000b1; 11.33</td><td valign="top" align="left" rowspan="1" colspan="1">34.42 &#x000b1; 8.22</td><td valign="top" align="left" rowspan="1" colspan="1">0.30</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Length of Stay, day (mean &#x000b1; SD)</td><td valign="top" align="left" rowspan="1" colspan="1">1.00 &#x000b1; 0.0001</td><td valign="top" align="left" rowspan="1" colspan="1">1.02 &#x000b1; 0.14</td><td valign="top" align="left" rowspan="1" colspan="1">0.74</td></tr></tbody></table></table-wrap></floats-group></article>